ANIP Earnings
Latest Revenue266.0M
Latest Net Income24.7M
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q2 2026 | $1.09 | 266.0M | 24.7M | +25.9% | +194.6% |
| Q1 2026 | $1.31 | 237.5M | 29.5M | +20.5% | +87.1% |
| Q4 2025 | $1.23 | 247.1M | 27.5M | +29.6% | +323.6% |
| Q3 2025 | $1.19 | 227.8M | 26.6M | +53.6% | +193.7% |
| Q2 2025 | $0.37 | 211.4M | 8.5M | +53.1% | +364.3% |
| Q1 2025 | $0.70 | 197.1M | 15.7M | +43.4% | -16.7% |
| Q4 2024 | -$0.55 | 190.6M | -10276000 | +44.8% | -1,475.0% |
| Q3 2024 | -$1.27 | 148.3M | -24166000 | +12.5% | -376.1% |
| Q2 2024 | -$0.14 | 138.0M | -2287000 | — | — |
| Q1 2024 | $0.84 | 137.4M | 18.2M | — | — |
| Q4 2023 | $0.04 | 131.7M | 1.2M | — | — |
| Q3 2023 | $0.46 | 131.8M | 9.9M | — | — |
ANI Pharmaceuticals (ANIP) — Earnings